NO177264C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten

Info

Publication number
NO177264C
NO177264C NO900186A NO900186A NO177264C NO 177264 C NO177264 C NO 177264C NO 900186 A NO900186 A NO 900186A NO 900186 A NO900186 A NO 900186A NO 177264 C NO177264 C NO 177264C
Authority
NO
Norway
Prior art keywords
analogous process
benzazepines
compounds
preparation
intermediates
Prior art date
Application number
NO900186A
Other languages
English (en)
Norwegian (no)
Other versions
NO900186D0 (no
NO177264B (no
NO900186L (no
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO900186D0 publication Critical patent/NO900186D0/no
Publication of NO900186L publication Critical patent/NO900186L/no
Publication of NO177264B publication Critical patent/NO177264B/no
Publication of NO177264C publication Critical patent/NO177264C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO900186A 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten NO177264C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (4)

Publication Number Publication Date
NO900186D0 NO900186D0 (no) 1990-01-12
NO900186L NO900186L (no) 1990-01-12
NO177264B NO177264B (no) 1995-05-08
NO177264C true NO177264C (no) 1995-08-16

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900186A NO177264C (no) 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten

Country Status (13)

Country Link
EP (2) EP0363353B1 (xx)
JP (1) JPH0678317B2 (xx)
AT (1) ATE78467T1 (xx)
AU (1) AU617651B2 (xx)
DE (1) DE3780649T2 (xx)
DK (1) DK162889C (xx)
ES (1) ES2043623T3 (xx)
FI (1) FI93212C (xx)
GR (1) GR3006671T3 (xx)
HU (1) HU203537B (xx)
NO (1) NO177264C (xx)
WO (1) WO1989000561A1 (xx)
ZA (1) ZA875183B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
CA2075181C (en) * 1990-02-02 1997-12-09 Theodros Asberom 4,5-bridged-2,3,4,5-tetrahydro-1h-3-benzazepine-7-ols
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
CN1688584A (zh) * 2002-08-29 2005-10-26 先灵公司 治疗肥胖和中枢神经系统疾病的选择性d1/d5受体拮抗剂
MXPA05012572A (es) * 2003-05-22 2006-02-08 Schering Corp Derivado de 5-h-benzo[d]naft[2,1-b]azepina como antagonistas selectivos del receptor d1/d5 para el tratamiento de la obesidad y trastornos del sistema nervioso central.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
EP0254737B1 (en) * 1986-01-16 1990-07-25 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
AU617651B2 (en) 1991-12-05
ZA875183B (en) 1988-04-08
WO1989000561A1 (en) 1989-01-26
JPH0678317B2 (ja) 1994-10-05
DK9390A (da) 1990-03-12
FI93212B (fi) 1994-11-30
DE3780649T2 (de) 1992-12-10
NO900186D0 (no) 1990-01-12
JPH02504629A (ja) 1990-12-27
DK162889B (da) 1991-12-23
EP0363353B1 (en) 1992-07-22
DK162889C (da) 1992-05-11
ES2043623T3 (es) 1994-01-01
NO177264B (no) 1995-05-08
ATE78467T1 (de) 1992-08-15
DE3780649D1 (de) 1992-08-27
FI900175A0 (fi) 1990-01-12
DK9390D0 (da) 1990-01-12
GR3006671T3 (xx) 1993-06-30
EP0299101A1 (en) 1989-01-18
HU203537B (en) 1991-08-28
FI93212C (fi) 1995-03-10
EP0299101B1 (en) 1992-09-23
NO900186L (no) 1990-01-12
EP0363353A1 (en) 1990-04-18
AU8037887A (en) 1989-02-13

Similar Documents

Publication Publication Date Title
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
FI20000353A (fi) 3,4,4-trisubstituoidun piperidinyyli-N-alkyylikarboksylaatin valmistus ja välituotteet
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DZ2420A1 (fr) Formulations nouvelles comprenant l'amoxycilline et du clavulanate et procédé pour leur préparation.
AU1331588A (en) Method for treatment of alcohol abuse
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
IE870112L (en) Fused benzazepines and intermediates thereof
FI970068A0 (fi) Menetelmä 2-(1-atsabisyklo/2,2,2/okt-3-yyli)-2,4,5,6-tetrahydro-1H-bens/de/isokinolin-1-onin ja välituotteen valmistamiseksi
NO177264C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten
PT93986A (pt) Processo para a preparacao de intermediarios diazabiciclicos
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
NO178622C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive kynurensyrederivater, samt mellomprodukter egnet for fremstilling derav
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
PT97099A (pt) Processo de preparacao de compostos da pirazina e de composicoes farmaceuticas que o contem
FR2716455B1 (fr) Procédé de préparation d'hétérocycles azotés polyhydroxylés énantiomériquement purs.
FR2561523B1 (fr) Nouvelles preparations d'allergenes, leur procede d'obtention et leur application en tant qu'agents de desensibilisation